A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.), together with its subsidiaries, is a healthcare technology and analytics company spanning across the three pillars of healthcare: Payer, Provider and Life Science. Our portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (“AI”)-enhanced solutions to help improve health outcomes and reduce costs. In particular, our portfolio, offering some of the most comprehensive solutions in our industry today, helps our clients advance the quality and efficiency of healthcare by providing electronic health records (“EHR”), financial management, population health management, deidentified data and patient communication solutions. Built on open integrated platforms, our solutions enable users to streamline workflows, leverage functionality from other software vendors and exchange data.
| Metric | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 588M | 588M | 577M | 556M | 1.6B | 1.6B |
| Net Income | -86M | -86M | 140M | 696M | -182M | 364M |
| EPS | $-0.77 | $-0.77 | $1.01 | $4.37 | $-1.10 | $2.07 |
| Free Cash Flow | 114M | 114M | -79M | -108M | 30M | 38M |
| ROIC | -2.8% | -3.1% | 4.5% | 56.0% | -9.9% | 16.5% |
| Gross Margin | 52.5% | 52.5% | 48.9% | 47.5% | 37.4% | 38.4% |
| Debt/Equity | 0.20 | 0.20 | 0.26 | 0.10 | 0.71 | 0.43 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -27M | -27M | 77M | 746M | -100M | -168M |
| Operating Margin | -4.6% | -4.6% | 13.3% | 134.1% | -6.1% | -10.4% |
| ROE | -8.5% | -7.3% | 9.2% | 41.8% | -12.8% | 27.2% |
| Shares Outstanding | 112M | 112M | 138M | 159M | 166M | 176M |
Veradigm Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 4.3x vs a median of 17.5x. The company's 5-year average ROIC is 12.8% with a gross margin of 44.9%. Total shareholder yield (buybacks) is 46.4%. At current prices, the estimated annualized return to fair value is +31.4%.
Veradigm Inc. (MDRX) has a 5-year average return on invested capital (ROIC) of 12.8%. This indicates solid capital allocation.
Veradigm Inc. (MDRX) has a market capitalization of $505M. It is classified as a small-cap stock.
Veradigm Inc. (MDRX) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 46.39%.
Veradigm Inc. (MDRX) operates in the Services-Computer Integrated Systems Design industry, within the Technology sector.
Veradigm Inc. (MDRX) reported annual revenue of $588 million in its most recent fiscal year, based on SEC EDGAR filings.
Veradigm Inc. (MDRX) has a net profit margin of -14.7%. The company is currently unprofitable.
Veradigm Inc. (MDRX) generated $114 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Veradigm Inc. (MDRX) has a debt-to-equity ratio of 0.20. This indicates a conservatively financed balance sheet.
Veradigm Inc. (MDRX) reported earnings per share (EPS) of $-0.77 in its most recent fiscal year.
Veradigm Inc. (MDRX) has a return on equity (ROE) of -7.3%. A negative ROE may indicate losses or negative equity.
Veradigm Inc. (MDRX) has a 5-year average gross margin of 44.9%. This indicates decent pricing power.
The Ledger Terminal provides 14 years of financial data for Veradigm Inc. (MDRX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Veradigm Inc. (MDRX) has a book value per share of $9.06, based on its most recent annual SEC filing.